Furthermore, the MDS BM microenvironment inhibited the growth of resident BM hematopoietic cells, likely through an elevated secretion of interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α), and interleukin 6 (IL-6) [13,34]. The gene discussed is IL6; the disease is myelodysplastic syndrome.